Results 31 to 40 of about 16,265,183 (153)

Coagulation Profile in Type 2 Diabetes Mellitus and its Association with Glycaemic Control and Long-term Complications: A Cross-sectional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Diabetes Mellitus (DM) causes numerous complications due to the formation of Advanced Glycation End-products (AGEs) in the presence of persistent hyperglycaemia.
Anindita Banerjee   +3 more
doaj   +1 more source

Abnormal activated partial thromboplastin time and malignancy

open access: yes, 2011
Malignancy often results in clotting abnormalities. The aetiology of haemostasis problems in cancer is complex, and is still not completely understood. We describe a case of a patient with malignant mesothelioma, who was found to have elevated activated
H Hambley, M Delicata
core   +1 more source

Evaluation of Coagulation Profile and Transfusion Support in Pre-eclampsia Patients: A Cross-sectional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Pre-eclampsia (PE) is an obstetric disorder characterised by high morbidity and mortality rates, yet it lacks a definitive etiology.
Sivaranjani Vijayasundaram   +3 more
doaj   +1 more source

Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients.

open access: yesPLoS ONE, 2022
BackgroundCOVID-19 is a viral disease caused by a new strain of corona virus. Currently, prognosis and risk stratification of COVID-19 patients is done by the disease's clinical presentation.
Esayas Tekle   +8 more
doaj   +1 more source

Variation of activated partial thromboplastin time according to age and sex in a large population study: analytical and clinical implications.

open access: yes, 2012
Variation of activated partial thromboplastin time according to age and sex in a large population study: analytical and clinical ...
Borghi L.   +5 more
core   +1 more source

Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time [PDF]

open access: yes, 2010
The measurement of blood clotting time is important in a range of clinical applications such as assessing coagulation disorders and controlling the effect of various anticoagulant drug therapies.
Dudek, Magdalena   +21 more
core   +1 more source

A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen [PDF]

open access: yes, 2002
The wide availability of fibrinogen estimations based on the prothrombin time (PT-Fg) has caused concern about the variability and clinical utility of fibrinogen assays.
Lowe, G.D.O.   +9 more
core   +4 more sources

PARTIAL THROMBOPLASTIN TIME CHANGES IN ASTHMA

open access: yesJournal of Research in Medical Sciences, 2003
Study objective: To exam the effect of asthma on- coagulation pathway. Methods: Case control study with 73 asthmatic pagtients at different age. Results: We show that PIT in asthmatic patients is longer than in control group (P < 0.0001). We
A MIRALAEI, F AFSHINNIA
doaj  

Activated partial thromboplastin time maybe associated with the prognosis of papillary thyroid carcinoma

open access: yesOpen Chemistry, 2022
Hemostasis markers associated with tumors have been widely studied. However, the associations between the coagulation factors and papillary thyroid carcinoma (PTC) prognosis remain unclear.
Wang Yanhai   +5 more
doaj   +1 more source

Interference of spurious haemolysis on prothrombin time, activated partial thromboplastin time, and fibrinogen.

open access: yes, 2014
Interference of spurious haemolysis on prothrombin time, activated partial thromboplastin time, and ...
LIPPI, Giuseppe, Ippolito L.
core   +1 more source

Home - About - Disclaimer - Privacy